Vanguard Group’s CG Oncology CGON Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $154M | Buy |
5,906,511
+70,191
| +1% | +$1.82M | ﹤0.01% | 1639 |
|
|
2025
Q1 | $143M | Sell |
5,836,320
-24,762
| -0.4% | -$606K | ﹤0.01% | 1634 |
|
|
2024
Q4 | $168M | Buy |
5,861,082
+779,730
| +15% | +$22.4M | ﹤0.01% | 1621 |
|
|
2024
Q3 | $192M | Buy |
5,081,352
+2,837,231
| +126% | +$107M | ﹤0.01% | 1562 |
|
|
2024
Q2 | $70.8M | Buy |
2,244,121
+19,103
| +0.9% | +$603K | ﹤0.01% | 2006 |
|
|
2024
Q1 | $97.7M | Buy |
+2,225,018
| New | +$97.7M | ﹤0.01% | 1884 |
|